Kathryn Rodriguez
University of South Florida
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kathryn Rodriguez.
Journal of Thoracic Disease | 2016
Frank O. Velez-Cubian; Wei Wei Zhang; Kathryn Rodriguez; Matthew R. Thau; Emily Ng; Carla Moodie; Joseph Garrett; Jacques-Pierre Fontaine; Eric M. Toloza
BACKGROUND Patients with smaller body surface area (BSA) have smaller pleural cavities, which limit visualization and instrument mobility during video-assisted thoracoscopic surgery (VATS). We investigated the effects of BSA on outcomes with robotic-assisted VATS lobectomy. METHODS We analyzed 208 consecutive patients who underwent robotic-assisted lobectomy over 34 months. Patients were separated into group A (BSA ≤1.65 m(2)) and group B (BSA >1.65 m(2)). Operative times, estimated blood loss (EBL), conversions to thoracotomy, complications, hospital length of stay (LOS), and in-hospital mortality were compared. RESULTS Group A had 40 patients (BSA 1.25-1.65 m(2)), and group B had 168 patients (BSA 1.66-2.86 m(2)). Median skin-to-skin operative times [± standard error of the mean (SEM)] were 169±16 min for group A and 176±6 min for group B (P=0.34). Group A had median EBL of 150±96 mL compared to 200±24 mL for group B (P=0.37). Overall conversion rate to thoracotomy was 8/40 (20.0%) in group A versus 12/168 (7.1%) in group B (P=0.03); while emergent conversion for bleeding was 2/40 (5.0%) in group A versus 5/168 (3.0%) in group B (P=0.62). Postoperative complications occurred in 12/40 (30.0%) in group A, compared to 66/168 (39.3%) in group B (P=0.28). Patients from both groups had median hospital LOS of 5 days (P=0.68) and had similar in-hospital mortality. CONCLUSIONS Patients with BSA ≤1.65 m(2) have similar perioperative outcomes and complication risks as patients with larger BSA. Patients with BSA ≤1.65 m(2) have a higher overall conversion rate to thoracotomy, but similar conversion rate for bleeding as patients with larger BSA. Robotic-assisted pulmonary lobectomy is feasible and safe in patients with small body habitus.
Journal of Thoracic Disease | 2016
Emily Ng; Frank O. Velez-Cubian; Kathryn Rodriguez; Matthew R. Thau; Carla Moodie; Joseph Garrett; Jacques P. Fontaine; Eric M. Toloza
BACKGROUND In this study, we sought to investigate the effect of post-operative atrial fibrillation (POAF) after robotic-assisted video-thoracoscopic pulmonary lobectomy on comorbid postoperative complications, chest tube duration, and hospital length of stay (LOS). METHODS We retrospectively analyzed prospectively collected data from 208 consecutive patients who underwent robotic-assisted pulmonary lobectomy by one surgeon for known or suspected lung cancer. Postoperatively, 39 (18.8%) of these patients experienced POAF during their hospital stay. The occurrence of postoperative complications other than POAF, chest tube duration, and hospital LOS were analyzed in patients with POAF and without POAF. Statistical significance (P≤0.05) was determined by unpaired Students t-test or by Chi-square test. RESULTS Of patients with POAF, 46% also had other concurrent postoperative complications, while only 31% of patients without POAF experienced complications. The average number of postoperative complications experienced by patients with POAF was significantly higher than that experienced by those without POAF (0.9 vs. 0.4, P<0.05). Median chest tube duration in POAF patients (6 days) was significantly higher than in patients without POAF (4 days). A similar result was also seen with hospital LOS, with the median hospital LOS of 8 days in POAF patients being significantly longer than in those without POAF, whose median hospital LOS was 4 days. No other significant difference was detected between the two groups of patients. CONCLUSIONS This study demonstrated the association between the incidence of POAF and a more complicated hospital course. Further studies are needed to determine whether confounders were involved in this association.
Surgical Innovation | 2017
Bryce Montané; Kavian Toosi; Frank O. Velez-Cubian; Maria F. Echavarria; Matthew R. Thau; Raj A. Patel; Kathryn Rodriguez; Carla Moodie; Joseph Garrett; Jacques P. Fontaine; Eric M. Toloza
Objective. We investigated whether higher body mass index (BMI) affects perioperative and postoperative outcomes after robotic-assisted video-thoracoscopic pulmonary lobectomy. Methods. We retrospectively studied all patients who underwent robotic-assisted pulmonary lobectomy by one surgeon between September 2010 and January 2015. Patients were grouped according to the World Health Organization’s definition of obesity, with “obese” being defined as BMI >30.0 kg/m2. Perioperative outcomes, including intraoperative estimated blood loss (EBL) and postoperative complication rates, were compared. Results. Over 53 months, 287 patients underwent robotic-assisted pulmonary lobectomy, with 7 patients categorized as “underweight,” 94 patients categorized as “normal weight,” 106 patients categorized as “overweight,” and 80 patients categorized as “obese.” Because of the relatively low sample size, “underweight” patients were excluded from this study, leaving a total cohort of 280 patients. There was no significant difference in intraoperative complication rates, conversion rates, perioperative outcomes, or postoperative complication rates among the 3 groups, except for lower risk of prolonged air leaks ≥7 days and higher risk of pneumonia in patients with obesity. Conclusions. Patients with obesity do not have increased risk of intraoperative or postoperative complications, except for pneumonia, compared with “normal weight” and “overweight” patients. Robotic-assisted pulmonary lobectomy is safe and effective for patients with high BMI.
Journal of Geriatric Oncology | 2017
Kathryn S. Kass; Frank O. Velez-Cubian; Wei Wei Zhang; Kavian Toosi; Tawee Tanvetyanon; Kathryn Rodriguez; Matthew R. Thau; Joseph Garrett; Carla Moodie; Jacques P. Fontaine; Eric M. Toloza
OBJECTIVES We investigated whether advanced age affects peri-operative outcomes after robotic-assisted pulmonary lobectomies. MATERIALS AND METHODS We retrospectively analyzed patients who underwent robotic-assisted lobectomy by one surgeon over a 5-year period. Rates of postoperative complications were compared according to age group. Other outcomes, such as intraoperative complications, hospital length of stay (LOS), and in-hospital mortality, were also compared. RESULTS A total of 287 patients were included (mean age 67.1yr). Group A had 65 patients of advanced age≥75yr (range 75-87yr; 37 men, 28 women); Group B had 222 patients aged <75yr (range 29-74yr; 95 men, 127 women). Group A had 10/65 (15.4%) patients with robotic-related intraoperative complications, compared to 10/222 (4.5%) for Group B (p=0.002), with the most frequent intraoperative complications being bleeding from a pulmonary vessel (10.8% vs. 4.5%, p=0.06), bronchial injury (3.1% vs. 0.9%, p=0.18), and injury to the phrenic or recurrent laryngeal nerve (1.5% vs. 0.4%, p=0.33). There were 28/65 (43.1%) patients in Group A with postoperative complications compared to 76/222 (34.2%) in Group B (p=0.19). While operative times were similar (p=0.42), Group A had longer median hospital LOS of 6±0.9days compared to 4±0.3days for Group B (p=0.02). CONCLUSION While younger patients have lower risk of robotic-related intraoperative complications and shorter hospital LOS, elderly patients do not have increased overall or emergent conversion rates to open lobectomy, overall postoperative complications rates, or in-house mortality compared to younger patients. Thus, robotic-assisted pulmonary lobectomy is feasible and relatively safe for patients of advanced age.
Cancer Control | 2014
Cynthia L. Harris; Eric M. Toloza; Jason B. Klapman; Shivakumar Vignesh; Kathryn Rodriguez; Frank J. Kaszuba
Journal of Thoracic Disease | 2016
Frank O. Velez-Cubian; Kathryn Rodriguez; Matthew R. Thau; Carla Moodie; Joseph Garrett; Jacques P. Fontaine; Eric M. Toloza
Chest | 2014
Frank O. Velez-Cubian; Wei Wei Zhang; Kathryn Rodriguez; Matthew R. Thau; Carla Moodie; Joseph Garrett; Jacques-Pierre Fontaine; Lary A. Robinson; Eric M. Toloza
Interactive Cardiovascular and Thoracic Surgery | 2014
Emily Ng; Kathryn Rodriguez; Frank O. Velez-Cubian; Matthew R. Thau; Wei Wei Zhang; Carla Moodie; Joseph Garrett; Jacques-Pierre Fontaine; Lary A. Robinson; Eric M. Toloza
Chest | 2014
Eric M. Toloza; Kathryn Rodriguez; Christian Sobky; Lori Brown; Joseph Garrett; Christy Chai; Carla Moodie; Rajendra Bhati; Gerard Mosiello; Jonathan S. Zager
Chest | 2014
Kathryn Rodriguez; Frank O. Velez-Cubian; Wei Wei Zhang; Tawee Tanvetyanon; Matthew R. Thau; Carla Moodie; Joseph Garrett; Jacques-Pierre Fontaine; Lary A. Robinson; Eric M. Toloza